Stay updated on UB-221 Safety & Efficacy in CSU Patients Clinical Trial
Sign up to get notified when there's something new on the UB-221 Safety & Efficacy in CSU Patients Clinical Trial page.

Latest updates to the UB-221 Safety & Efficacy in CSU Patients Clinical Trial page
- Check4 days agoChange DetectedThe page now displays a site-wide notice about a lapse in government funding and the NIH operations status, and it shows a new revision tag (v3.4.1) replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check11 days agoChange DetectedThe page adds a glossary toggle and updates metadata labels, including 'Last Update Submitted that Met QC Criteria' and the revision string 'v3.4.0'. These changes are cosmetic and do not modify the study details, eligibility criteria, or data presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe revision label on the page changed from v3.3.3 to v3.3.4. This appears to be a minor maintenance update that does not modify the study details or user interactions.SummaryDifference0.1%

- Check46 days agoChange DetectedAdded a new Revision: v3.3.3 notice and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page.SummaryDifference0.1%

- Check75 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2; this is a minor metadata update that does not affect study details, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedRemoval of the government funding status notice banner; core study details such as title, dates, enrollment, and eligibility remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to UB-221 Safety & Efficacy in CSU Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UB-221 Safety & Efficacy in CSU Patients Clinical Trial page.